S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.
about
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapyExport of sphingosine-1-phosphate and cancer progressionSphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor MicroenvironmentSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapySphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel DiseaseSphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration.CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.An update on the biology of sphingosine 1-phosphate receptors.Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1)Hypothalamic S1P/S1PR1 axis controls energy homeostasis in Middle-Aged Rodents: the reversal effects of physical exercise.Diffuse large B cell lymphoma: molecular targeted therapy.Oncogenic properties of sphingosine kinases in haematological malignancies.The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.Targeting sphingosine-1-phosphate signaling for cancer therapy.miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysisSphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance.The role of G protein-coupled receptors in lymphoid malignancies.FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.Sphingolipid metabolism in cancer signalling and therapy.Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma.
P2860
Q26996672-7D09F03F-4861-4A6A-97ED-DB0AF7579A21Q27009557-D2DBB8CE-D479-45D9-99D9-AB1BB51D1699Q28069459-4FBD9611-32B9-4E77-AE1F-5510DBE136ABQ28080262-F2B9D2BD-8CC2-49B3-BF8F-752EFFB14501Q30235011-79FCFFF4-A3E3-45F3-A080-62019ED8D6A6Q30416979-E91DE860-2A44-4C0B-B016-95231925189EQ33808334-50C14646-961E-4E4A-957A-C1FAFCFC1249Q33945064-AE66E4BE-B78F-4C25-ABE1-DC87094E58AEQ34364844-8DAF0D6C-9A04-451A-870B-365A19D6D9BFQ34695303-68486E14-E38E-435D-BAC1-4EA13BF346E1Q35145464-05B90570-B47A-4C83-8310-2E7DFA044E30Q36627430-B330A0AD-00EB-4581-8D1F-56FDAD3F5AF0Q36729372-DBB865DE-40D0-4CEF-AA82-742A8759A7E2Q37643505-09679DFE-B589-4482-9B82-32C7BF2B04C6Q38053983-BB6654AD-6B50-4BCA-8816-F9AE97B62C1BQ38092176-C3EC9109-4224-45FA-8FB9-C23B88243A83Q38546700-A0C0EE2F-088D-42AA-A267-075B49666FDDQ38880225-0BE3BE00-83CC-4C96-9E41-8DFC90BD039AQ38909416-E3F99CC1-5039-4C84-84AD-7B52E5448857Q39090949-0F85650A-DC86-4AF1-91D7-8B523FA7F229Q39114974-1D0353B9-ECA8-4BC0-9831-8899E8EA47FCQ39379449-6AED36C7-287F-4297-AAC9-19B2CAA6FACFQ39882004-3B14565C-3A4E-4A8B-95AF-1AB1BB41F050Q39991614-6B3D5921-9454-45A4-9752-E3A896BE0FCEQ46444617-D3BEB5DB-B393-4439-A6E9-831E756BB360Q47960121-CA0F6E65-9C37-40DA-A15A-F7EEA1E7A0B1Q48208586-DB5A594A-2E20-409D-AFC9-23316593044AQ49950035-7E5C3214-03C9-4376-82D2-39FE733BC39BQ53808235-CA6BDC4E-B688-46CE-8E6D-1E3739810585
P2860
S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma.
@ast
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma.
@en
type
label
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma.
@ast
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma.
@en
prefLabel
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma.
@ast
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma.
@en
P2093
P2860
P1433
P1476
S1PR1 is an effective target t ...... diffuse large B-cell lymphoma
@en
P2093
Anna Scuto
Brian Armstrong
Claudia Kowolik
Heehyoung Lee
Lawrence M Weiss
Stephen Forman
P2860
P304
P356
10.1182/BLOOD-2011-12-399030
P407
P50
P577
2012-06-28T00:00:00Z